All 0 3 0 3 O
patients 4 12 4 12 O
with 13 17 13 17 O
ovarian 18 25 18 25 B-cancer
, 25 26 25 26 O
fallopian 27 36 27 36 B-cancer
tube 37 41 37 41 I-cancer
or 42 44 42 44 O
primary 45 52 45 52 B-cancer
peritoneal 53 63 53 63 I-cancer
cancer 64 70 64 70 I-cancer
and 71 74 71 74 O
ovarian 75 82 75 82 B-cancer
carcinosarcoma 83 97 83 97 I-cancer
must 98 102 98 102 O
have 103 107 103 107 O
recurrent 108 117 108 117 O
disease 118 125 118 125 O
, 125 126 125 126 O
and 127 130 127 130 O
only 131 135 131 135 O
one 136 139 136 139 O
prior 140 145 140 145 O
line 146 150 146 150 O
of 151 153 151 153 O
chemotherapy 154 166 154 166 B-treatment
that 167 171 167 171 O
must 172 176 172 176 O
have 177 181 177 181 O
been 182 186 182 186 O
platinum 187 195 187 195 B-treatment
- 195 196 195 196 I-treatment
based 196 201 196 201 I-treatment
chemotherapy 202 214 202 214 I-treatment
for 215 218 215 218 O
the 219 222 219 222 O
management 223 233 223 233 O
of 234 236 234 236 O
primary 237 244 237 244 O
disease 245 252 245 252 O
. 252 253 252 253 O
This 254 258 254 258 O
initial 259 266 259 266 O
platinum 267 275 267 275 B-treatment
- 275 276 275 276 I-treatment
based 276 281 276 281 I-treatment
treatment 282 291 282 291 I-treatment
may 292 295 292 295 O
have 296 300 296 300 O
included 301 309 301 309 O
intraperitoneal 310 325 310 325 B-treatment
therapy 326 333 326 333 I-treatment
, 333 334 333 334 O
consolidation 335 348 335 348 O
/ 348 349 348 349 O
maintenance 349 360 349 360 O
and/or 361 367 361 367 O
biologic 368 376 368 376 O
/ 376 377 376 377 O
targeted 377 385 377 385 O
agents 386 392 386 392 O
( 393 394 393 394 O
e.g. 394 398 394 398 O
, 398 399 398 399 O
bevacizumab 400 411 400 411 B-treatment
, 411 412 411 412 O
PARP 413 417 413 417 B-treatment
inhibitor 418 427 418 427 I-treatment
) 427 428 427 428 O
as 429 431 429 431 O
part 432 436 432 436 O
of 437 439 437 439 O
first 440 445 440 445 O
- 445 446 445 446 O
line 446 450 446 450 O
treatment 451 460 451 460 O

Any 0 3 461 464 O
hormonal 4 12 465 473 B-treatment
therapy 13 20 474 481 I-treatment
directed 21 29 482 490 O
at 30 32 491 493 O
the 33 36 494 497 O
malignant 37 46 498 507 B-cancer
tumor 47 52 508 513 I-cancer
must 53 57 514 518 O
be 58 60 519 521 O
discontinued 61 73 522 534 O
at 74 76 535 537 O
least 77 82 538 543 O
one 83 86 544 547 B-upper_bound
week 87 91 548 552 I-upper_bound
prior 92 97 553 558 I-upper_bound
to 98 100 559 561 O
study 101 106 562 567 O
treatment 107 116 568 577 B-treatment
initiation 117 127 578 588 O

Any 0 3 589 592 O
investigation 4 17 593 606 B-treatment
agents 18 24 607 613 I-treatment
must 25 29 614 618 O
be 30 32 619 621 O
discontinued 33 45 622 634 O
at 46 48 635 637 O
least 49 54 638 643 O
30 55 57 644 646 B-lower_bound
days 58 62 647 651 I-lower_bound
prior 63 68 652 657 I-lower_bound
to 69 71 658 660 O
study 72 77 661 666 O
treatment 78 87 667 676 B-treatment
initiation 88 98 677 687 O

Any 0 3 688 691 O
life 4 8 692 696 B-chronic_disease
- 8 9 696 697 I-chronic_disease
threatening 9 20 697 708 I-chronic_disease
illness 21 28 709 716 I-chronic_disease
, 28 29 716 717 O
medical 30 37 718 725 O
condition 38 47 726 735 O
or 48 50 736 738 O
organ 51 56 739 744 O
system 57 63 745 751 O
dysfunction 64 75 752 763 O
which 76 81 764 769 O
, 81 82 769 770 O
in 83 85 771 773 O
the 86 89 774 777 O
investigator 90 102 778 790 O
's 102 104 790 792 O
opinion 105 112 793 800 O
, 112 113 800 801 O
could 114 119 802 807 O
compromise 120 130 808 818 O
the 131 134 819 822 O
subject 135 142 823 830 O
's 142 144 830 832 O
safety 145 151 833 839 O
, 151 152 839 840 O
or 153 155 841 843 O
put 156 159 844 847 O
the 160 163 848 851 O
study 164 169 852 857 O
outcomes 170 178 858 866 O
at 179 181 867 869 O
undue 182 187 870 875 O
risk 188 192 876 880 O

Any 0 3 881 884 O
other 4 9 885 890 O
prior 10 15 891 896 B-treatment
therapy 16 23 897 904 I-treatment
directed 24 32 905 913 O
at 33 35 914 916 O
the 36 39 917 920 O
malignant 40 49 921 930 B-cancer
tumor 50 55 931 936 I-cancer
, 55 56 936 937 O
including 57 66 938 947 O
chemotherapy 67 79 948 960 B-treatment
, 79 80 960 961 O
biologic 81 89 962 970 B-treatment
/ 89 90 970 971 I-treatment
targeted 90 98 971 979 I-treatment
therapy 99 106 980 987 I-treatment
and 107 110 988 991 O
immunologic 111 122 992 1003 B-treatment
therapy 123 130 1004 1011 I-treatment
, 130 131 1011 1012 O
must 132 136 1013 1017 O
be 137 139 1018 1020 O
discontinued 140 152 1021 1033 O
at 153 155 1034 1036 O
least 156 161 1037 1042 O
3 162 163 1043 1044 B-lower_bound
weeks 164 169 1045 1050 I-lower_bound
prior 170 175 1051 1056 I-lower_bound
to 176 178 1057 1059 O
study 179 184 1060 1065 O
treatment 185 194 1066 1075 B-treatment
initiation 195 205 1076 1086 O

Any 0 3 1087 1090 O
prior 4 9 1091 1096 B-treatment
radiation 10 19 1097 1106 I-treatment
therapy 20 27 1107 1114 I-treatment
must 28 32 1115 1119 O
be 33 35 1120 1122 O
discontinued 36 48 1123 1135 O
at 49 51 1136 1138 O
least 52 57 1139 1144 O
4 58 59 1145 1146 B-lower_bound
weeks 60 65 1147 1152 I-lower_bound
prior 66 71 1153 1158 I-lower_bound
to 72 74 1159 1161 O
study 75 80 1162 1167 O
treatment 81 90 1168 1177 B-treatment
initiation 91 101 1178 1188 O

At 0 2 1189 1191 O
least 3 8 1192 1197 O
4 9 10 1198 1199 B-lower_bound
weeks 11 16 1200 1205 I-lower_bound
must 17 21 1206 1210 O
have 22 26 1211 1215 O
lapsed 27 33 1216 1222 O
since 34 39 1223 1228 O
major 40 45 1229 1234 B-treatment
surgery 46 53 1235 1242 I-treatment
( 54 55 1243 1244 O
e.g. 55 59 1244 1248 O
, 59 60 1248 1249 O
laparotomy 61 71 1250 1260 B-treatment
, 71 72 1260 1261 O
laparoscopy 73 84 1262 1273 B-treatment
, 84 85 1273 1274 O
thoracotomy 86 97 1275 1286 B-treatment
, 97 98 1286 1287 O
video 99 104 1288 1293 B-treatment
assisted 105 113 1294 1302 I-treatment
thoracoscopy 114 126 1303 1315 I-treatment
) 126 127 1315 1316 O
prior 128 133 1317 1322 O
to 134 136 1323 1325 O
study 137 142 1326 1331 B-treatment
treatment 143 152 1332 1341 I-treatment
initiation 153 163 1342 1352 O

Have 0 4 1353 1357 O
an 5 7 1358 1360 O
Eastern 8 15 1361 1368 B-clinical_variable
Cooperative 16 27 1369 1380 I-clinical_variable
Oncology 28 36 1381 1389 I-clinical_variable
Group 37 42 1390 1395 I-clinical_variable
( 43 44 1396 1397 I-clinical_variable
ECOG 44 48 1397 1401 I-clinical_variable
) 48 49 1401 1402 I-clinical_variable
performance 50 61 1403 1414 I-clinical_variable
status 62 68 1415 1421 I-clinical_variable
of 69 71 1422 1424 O
0 72 73 1425 1426 B-lower_bound
- 73 74 1426 1427 O
1 74 75 1427 1428 B-upper_bound

Neurologic 0 10 1429 1439 O
function 11 19 1440 1448 O
: 19 20 1448 1449 O
Neuropathy 21 31 1450 1460 B-chronic_disease
( 32 33 1461 1462 O
sensory 33 40 1462 1469 O
and 41 44 1470 1473 O
motor 45 50 1474 1479 O
) 50 51 1479 1480 O
less 52 56 1481 1485 O
than 57 61 1486 1490 O
or 62 64 1491 1493 O
equal 65 70 1494 1499 O
to 71 73 1500 1502 O
Grade 74 79 1503 1508 B-upper_bound
1 80 81 1509 1510 I-upper_bound

Patient 0 7 1511 1518 O
who 8 11 1519 1522 O
have 12 16 1523 1527 O
had 17 20 1528 1531 O
previous 21 29 1532 1540 B-treatment
treatment 30 39 1541 1550 I-treatment
with 40 44 1551 1555 I-treatment
selinexor 45 54 1556 1565 I-treatment

Patients 0 8 1566 1574 O
must 9 13 1575 1579 O
be 14 16 1580 1582 O
willing 17 24 1583 1590 O
and 25 28 1591 1594 O
able 29 33 1595 1599 O
to 34 36 1600 1602 O
swallow 37 44 1603 1610 O
oral 45 49 1611 1615 B-treatment
tablets 50 57 1616 1623 I-treatment

Patients 0 8 1624 1632 O
must 9 13 1633 1637 O
have 14 18 1638 1642 O
measurable 19 29 1643 1653 O
disease 30 37 1654 1661 O
( 38 39 1662 1663 O
RECIST 39 45 1663 1669 O
1.1 46 49 1670 1673 O
) 49 50 1673 1674 O
. 50 51 1674 1675 O
Measurable 52 62 1676 1686 O
disease 63 70 1687 1694 O
is 71 73 1695 1697 O
defined 74 81 1698 1705 O
as 82 84 1706 1708 O
at 85 87 1709 1711 O
least 88 93 1712 1717 O
one 94 97 1718 1721 B-lower_bound
lesion 98 104 1722 1728 B-clinical_variable
that 105 109 1729 1733 O
can 110 113 1734 1737 O
be 114 116 1738 1740 O
accurately 117 127 1741 1751 O
measured 128 136 1752 1760 O
in 137 139 1761 1763 O
at 140 142 1764 1766 O
least 143 148 1767 1772 O
one 149 152 1773 1776 O
dimension 153 162 1777 1786 O
( 163 164 1787 1788 O
longest 164 171 1788 1795 O
diameter 172 180 1796 1804 O
to 181 183 1805 1807 O
be 184 186 1808 1810 O
recorded 187 195 1811 1819 O
) 195 196 1819 1820 O
. 196 197 1820 1821 O
Each 198 202 1822 1826 O
lesion 203 209 1827 1833 O
must 210 214 1834 1838 O
be 215 217 1839 1841 O
greater 218 225 1842 1849 O
than 226 230 1850 1854 O
or 231 233 1855 1857 O
equal 234 239 1858 1863 O
to 240 242 1864 1866 O
10 243 245 1867 1869 B-lower_bound
mm 246 248 1870 1872 I-lower_bound
when 249 253 1873 1877 O
measured 254 262 1878 1886 O
by 263 265 1887 1889 O
CT 266 268 1890 1892 B-treatment
, 268 269 1892 1893 O
MRI 270 273 1894 1897 B-treatment
or 274 276 1898 1900 O
caliper 277 284 1901 1908 B-treatment
measurement 285 296 1909 1920 O
by 297 299 1921 1923 O
clinical 300 308 1924 1932 O
exam 309 313 1933 1937 O
; 313 314 1937 1938 O
or 315 317 1939 1941 O
greater 318 325 1942 1949 O
than 326 330 1950 1954 O
or 331 333 1955 1957 O
equal 334 339 1958 1963 O
to 340 342 1964 1966 O
20 343 345 1967 1969 B-lower_bound
mm 346 348 1970 1972 I-lower_bound
when 349 353 1973 1977 O
measured 354 362 1978 1986 O
by 363 365 1987 1989 O
chest 366 371 1990 1995 B-treatment
x 372 373 1996 1997 I-treatment
- 373 374 1997 1998 I-treatment
ray 374 377 1998 2001 I-treatment
. 377 378 2001 2002 O
Lymph 379 384 2003 2008 B-clinical_variable
nodes 385 390 2009 2014 I-clinical_variable
must 391 395 2015 2019 O
be 396 398 2020 2022 O
greater 399 406 2023 2030 O
than 407 411 2031 2035 O
or 412 414 2036 2038 O
equal 415 420 2039 2044 O
to 421 423 2045 2047 O
15 424 426 2048 2050 B-lower_bound
mm 427 429 2051 2053 I-lower_bound
in 430 432 2054 2056 O
short 433 438 2057 2062 O
axis 439 443 2063 2067 O
when 444 448 2068 2072 O
measured 449 457 2073 2081 O
by 458 460 2082 2084 O
CT 461 463 2085 2087 O
or 464 466 2088 2090 O
MRI 467 470 2091 2094 O

Patients 0 8 2095 2103 O
must 9 13 2104 2108 O
have 14 18 2109 2113 O
recovered 19 28 2114 2123 O
from 29 33 2124 2128 O
effects 34 41 2129 2136 O
of 42 44 2137 2139 O
recent 45 51 2140 2146 B-treatment
surgery 52 59 2147 2154 I-treatment
, 59 60 2154 2155 O
radiotherapy 61 73 2156 2168 B-treatment
, 73 74 2168 2169 O
chemotherapy 75 87 2170 2182 B-treatment
or 88 90 2183 2185 O
biologic 91 99 2186 2194 B-treatment
/ 99 100 2194 2195 I-treatment
targeted 100 108 2195 2203 I-treatment
therapy 109 116 2204 2211 I-treatment
to 117 119 2212 2214 O
baseline 120 128 2215 2223 O
or 129 131 2224 2226 O
CTCAE 132 137 2227 2232 B-clinical_variable
less 138 142 2233 2237 O
than 143 147 2238 2242 O
or 148 150 2243 2245 O
equal 151 156 2246 2251 O
to 157 159 2252 2254 O
Grade 160 165 2255 2260 B-upper_bound
1 166 167 2261 2262 I-upper_bound
( 168 169 2263 2264 O
excluding 169 178 2264 2273 O
alopecia 179 187 2274 2282 B-chronic_disease
or 188 190 2283 2285 O
other 191 196 2286 2291 O
non 197 200 2292 2295 O
- 200 201 2295 2296 O
clinically 201 211 2296 2306 O
significant 212 223 2307 2318 O
AE 224 226 2319 2321 O
's 226 228 2321 2323 O
) 228 229 2323 2324 O

Patients 0 8 2325 2333 O
of 9 11 2334 2336 O
childbearing 12 24 2337 2349 O
potential 25 34 2350 2359 O
must 35 39 2360 2364 O
have 40 44 2365 2369 O
a 45 46 2370 2371 O
negative 47 55 2372 2380 B-pregnancy
pregnancy 56 65 2381 2390 I-pregnancy
test 66 70 2391 2395 O
prior 71 76 2396 2401 O
to 77 79 2402 2404 O
the 80 83 2405 2408 O
study 84 89 2409 2414 O
entry 90 95 2415 2420 O
and 96 99 2421 2424 O
be 100 102 2425 2427 O
practicing 103 113 2428 2438 B-contraception_consent
an 114 116 2439 2441 I-contraception_consent
effective 117 126 2442 2451 I-contraception_consent
form 127 131 2452 2456 I-contraception_consent
of 132 134 2457 2459 I-contraception_consent
contraception 135 148 2460 2473 I-contraception_consent
. 148 149 2473 2474 O
Sexually 150 158 2475 2483 O
active 159 165 2484 2490 O
subjects 166 174 2491 2499 O
must 175 179 2500 2504 O
agree 180 185 2505 2510 B-contraception_consent
to 186 188 2511 2513 I-contraception_consent
use 189 192 2514 2517 I-contraception_consent
medically 193 202 2518 2527 I-contraception_consent
accepted 203 211 2528 2536 I-contraception_consent
barrier 212 219 2537 2544 I-contraception_consent
methods 220 227 2545 2552 I-contraception_consent
of 228 230 2553 2555 I-contraception_consent
contraception 231 244 2556 2569 I-contraception_consent
( 245 246 2570 2571 O
e.g. 246 250 2571 2575 O
, 250 251 2575 2576 O
male 252 256 2577 2581 B-contraception_consent
or 257 259 2582 2584 I-contraception_consent
female 260 266 2585 2591 I-contraception_consent
condom 267 273 2592 2598 I-contraception_consent
) 273 274 2598 2599 O
during 275 281 2600 2606 O
the 282 285 2607 2610 O
course 286 292 2611 2617 O
of 293 295 2618 2620 O
the 296 299 2621 2624 O
study 300 305 2625 2630 O
and 306 309 2631 2634 O
for 310 313 2635 2638 O
4 314 315 2639 2640 B-upper_bound
months 316 322 2641 2647 I-upper_bound
after 323 328 2648 2653 I-upper_bound
the 329 332 2654 2657 O
last 333 337 2658 2662 O
dose 338 342 2663 2667 O
of 343 345 2668 2670 O
study 346 351 2671 2676 B-treatment
drug 352 356 2677 2681 I-treatment
, 356 357 2681 2682 O
even 358 362 2683 2687 O
if 363 365 2688 2690 O
oral 366 370 2691 2695 B-contraception_consent
contraceptives 371 385 2696 2710 I-contraception_consent
are 386 389 2711 2714 O
also 390 394 2715 2719 O
used 395 399 2720 2724 O
. 399 400 2724 2725 O
All 401 404 2726 2729 O
subjects 405 413 2730 2738 O
of 414 416 2739 2741 O
reproductive 417 429 2742 2754 O
potential 430 439 2755 2764 O
must 440 444 2765 2769 O
agree 445 450 2770 2775 B-contraception_consent
to 451 453 2776 2778 I-contraception_consent
use 454 457 2779 2782 I-contraception_consent
both 458 462 2783 2787 I-contraception_consent
a 463 464 2788 2789 I-contraception_consent
barrier 465 472 2790 2797 I-contraception_consent
method 473 479 2798 2804 I-contraception_consent
and 480 483 2805 2808 I-contraception_consent
a 484 485 2809 2810 I-contraception_consent
second 486 492 2811 2817 I-contraception_consent
method 493 499 2818 2824 I-contraception_consent
of 500 502 2825 2827 I-contraception_consent
birth 503 508 2828 2833 I-contraception_consent
control 509 516 2834 2841 I-contraception_consent
during 517 523 2842 2848 O
the 524 527 2849 2852 O
course 528 534 2853 2859 O
of 535 537 2860 2862 O
the 538 541 2863 2866 O
study 542 547 2867 2872 O
and 548 551 2873 2876 O
for 552 555 2877 2880 O
4 556 557 2881 2882 O
months 558 564 2883 2889 O
after 565 570 2890 2895 O
the 571 574 2896 2899 O
last 575 579 2900 2904 O
dose 580 584 2905 2909 O
of 585 587 2910 2912 O
study 588 593 2913 2918 O
drug 594 598 2919 2923 O
. 598 599 2923 2924 O
Pregnant 600 608 2925 2933 B-pregnancy
women 609 614 2934 2939 B-gender
are 615 618 2940 2943 O
excluded 619 627 2944 2952 O
from 628 632 2953 2957 O
this 633 637 2958 2962 O
study 638 643 2963 2968 O
because 644 651 2969 2976 O
of 652 654 2977 2979 O
the 655 658 2980 2983 O
potential 659 668 2984 2993 O
for 669 672 2994 2997 O
teratogenic 673 684 2998 3009 O
or 685 687 3010 3012 O
abortifacient 688 701 3013 3026 O
effects 702 709 3027 3034 O

Patients 0 8 3035 3043 O
requiring 9 18 3044 3053 O
drainage 19 27 3054 3062 B-treatment
gastrostomy 28 39 3063 3074 I-treatment
( 40 41 3075 3076 O
e.g. 41 45 3076 3080 O
, 45 46 3080 3081 O
drainage 47 55 3082 3090 B-treatment
PEG 56 59 3091 3094 I-treatment
tube 60 64 3095 3099 I-treatment
) 64 65 3099 3100 O
and/or 66 72 3101 3107 O
parenteral 73 83 3108 3118 O
hydration 84 93 3119 3128 O
and/or 94 100 3129 3135 O
nutrition 101 110 3136 3145 O

Patients 0 8 3146 3154 O
who 9 12 3155 3158 O
are 13 16 3159 3162 B-pregnancy
pregnant 17 25 3163 3171 I-pregnancy

Patients 0 8 3172 3180 O
with 9 13 3181 3185 O
endometrial 14 25 3186 3197 B-cancer
cancer 26 32 3198 3204 I-cancer
or 33 35 3205 3207 O
endometrial 36 47 3208 3219 B-cancer
carcinosarcoma 48 62 3220 3234 I-cancer
may 63 66 3235 3238 O
either 67 73 3239 3245 O
be 74 76 3246 3248 O
chemotherapy 77 89 3249 3261 B-treatment
naive 90 95 3262 3267 I-treatment
OR 96 98 3268 3270 O
have 99 103 3271 3275 O
had 104 107 3276 3279 O
one 108 111 3280 3283 O
prior 112 117 3284 3289 B-treatment
line 118 122 3290 3294 I-treatment
of 123 125 3295 3297 I-treatment
chemotherapy 126 138 3298 3310 I-treatment
that 139 143 3311 3315 O
must 144 148 3316 3320 O
have 149 153 3321 3325 O
been 154 158 3326 3330 O
a 159 160 3331 3332 O
platinum 161 169 3333 3341 O
- 169 170 3341 3342 O
based 170 175 3342 3347 O
chemotherapy 176 188 3348 3360 O
regimen 189 196 3361 3368 O
in 197 199 3369 3371 O
the 200 203 3372 3375 O
adjuvant 204 212 3376 3384 O
or 213 215 3385 3387 O
advanced 216 224 3388 3396 O
/ 224 225 3396 3397 O
recurrent 225 234 3397 3406 O
setting 235 242 3407 3414 O
. 242 243 3414 3415 O
The 244 247 3416 3419 O
initial 248 255 3420 3427 O
platinum 256 264 3428 3436 B-treatment
- 264 265 3436 3437 I-treatment
based 265 270 3437 3442 I-treatment
treatment 271 280 3443 3452 I-treatment
may 281 284 3453 3456 O
have 285 289 3457 3461 O
included 290 298 3462 3470 O
consolidation 299 312 3471 3484 O
/ 312 313 3484 3485 O
maintenance 313 324 3485 3496 O
and/or 325 331 3497 3503 O
biologic 332 340 3504 3512 O
/ 340 341 3512 3513 O
targeted 341 349 3513 3521 O
agents 350 356 3522 3528 O
as 357 359 3529 3531 O
part 360 364 3532 3536 O
of 365 367 3537 3539 O
first 368 373 3540 3545 B-treatment
- 373 374 3545 3546 I-treatment
line 374 378 3546 3550 I-treatment
treatment 379 388 3551 3560 I-treatment
. 388 389 3560 3561 O
Patients 390 398 3562 3570 O
entering 399 407 3571 3579 O
the 408 411 3580 3583 O
trial 412 417 3584 3589 O
chemotherapy 418 430 3590 3602 O
naive 431 436 3603 3608 O
MUST 437 441 3609 3613 O
have 442 446 3614 3618 O
Stage 447 452 3619 3624 B-cancer
IVB 453 456 3625 3628 I-cancer
or 457 459 3629 3631 O
recurrent 460 469 3632 3641 O
disease 470 477 3642 3649 O
AND 478 481 3650 3653 O
have 482 486 3654 3658 O
disease 487 494 3659 3666 O
that 495 499 3667 3671 O
is 500 502 3672 3674 O
not 503 506 3675 3678 O
amenable 507 515 3679 3687 O
to 516 518 3688 3690 O
curative 519 527 3691 3699 O
intent 528 534 3700 3706 O

Patients 0 8 3707 3715 O
with 9 13 3716 3720 O
history 14 21 3721 3728 O
or 22 24 3729 3731 O
evidence 25 33 3732 3740 O
upon 34 38 3741 3745 O
physical 39 47 3746 3754 O
examination 48 59 3755 3766 O
of 60 62 3767 3769 O
CNS 63 66 3770 3773 B-chronic_disease
disease 67 74 3774 3781 I-chronic_disease
, 74 75 3781 3782 O
including 76 85 3783 3792 O
primary 86 93 3793 3800 B-cancer
brain 94 99 3801 3806 I-cancer
tumor 100 105 3807 3812 I-cancer
, 105 106 3812 3813 O
seizures 107 115 3814 3822 B-chronic_disease
which 116 121 3823 3828 O
are 122 125 3829 3832 O
not 126 129 3833 3836 O
controlled 130 140 3837 3847 O
, 140 141 3847 3848 O
any 142 145 3849 3852 O
brain 146 151 3853 3858 B-chronic_disease
metastases 152 162 3859 3869 I-chronic_disease
and/or 163 169 3870 3876 O
epidural 170 178 3877 3885 B-chronic_disease
disease 179 186 3886 3893 I-chronic_disease
, 186 187 3893 3894 O
or 188 190 3895 3897 O
history 191 198 3898 3905 O
of 199 201 3906 3908 O
cerebrovascular 202 217 3909 3924 B-chronic_disease
accident 218 226 3925 3933 I-chronic_disease
( 227 228 3934 3935 O
CVA 228 231 3935 3938 B-chronic_disease
, 231 232 3938 3939 O
stroke 233 239 3940 3946 B-chronic_disease
) 239 240 3946 3947 O
within 241 247 3948 3954 O
six 248 251 3955 3958 B-upper_bound
months 252 258 3959 3965 I-upper_bound
prior 259 264 3966 3971 I-upper_bound
to 265 267 3972 3974 O
the 268 271 3975 3978 O
first 272 277 3979 3984 O
date 278 282 3985 3989 O
of 283 285 3990 3992 O
study 286 291 3993 3998 O
treatment 292 301 3999 4008 O

Patients 0 8 4009 4017 O
with 9 13 4018 4022 O
macular 14 21 4023 4030 B-chronic_disease
degeneration 22 34 4031 4043 I-chronic_disease
, 34 35 4043 4044 O
uncontrolled 36 48 4045 4057 O
glaucoma 49 57 4058 4066 B-chronic_disease
, 57 58 4066 4067 O
or 59 61 4068 4070 O
markedly 62 70 4071 4079 O
decreased 71 80 4080 4089 O
visual 81 87 4090 4096 O
acuity 88 94 4097 4103 O

Tumors 0 6 4104 4110 B-cancer
within 7 13 4111 4117 O
a 14 15 4118 4119 O
previously 16 26 4120 4130 O
irradiated 27 37 4131 4141 O
field 38 43 4142 4147 O
will 44 48 4148 4152 O
be 49 51 4153 4155 O
designated 52 62 4156 4166 O
as 63 65 4167 4169 O
non 66 69 4170 4173 O
- 69 70 4173 4174 O
target 70 76 4174 4180 O
lesions 77 84 4181 4188 O
unless 85 91 4189 4195 O
progression 92 103 4196 4207 O
is 104 106 4208 4210 O
documented 107 117 4211 4221 O
or 118 120 4222 4224 O
a 121 122 4225 4226 O
biopsy 123 129 4227 4233 B-treatment
is 130 132 4234 4236 O
obtained 133 141 4237 4245 O
to 142 144 4246 4248 O
confirm 145 152 4249 4256 O
persistence 153 164 4257 4268 O
at 165 167 4269 4271 O
least 168 173 4272 4277 O
90 174 176 4278 4280 B-lower_bound
days 177 181 4281 4285 I-lower_bound
following 182 191 4286 4295 O
completion 192 202 4296 4306 O
of 203 205 4307 4309 O
radiation 206 215 4310 4319 B-treatment
therapy 216 223 4320 4327 I-treatment

Uncontrolled 0 12 4328 4340 O
active 13 19 4341 4347 B-chronic_disease
infection 20 29 4348 4357 I-chronic_disease
requiring 30 39 4358 4367 O
parenteral 40 50 4368 4378 B-treatment
antibiotics 51 62 4379 4390 I-treatment
, 62 63 4390 4391 O
antivirals 64 74 4392 4402 B-treatment
, 74 75 4402 4403 O
or 76 78 4404 4406 O
antifungals 79 90 4407 4418 B-treatment
within 91 97 4419 4425 O
one 98 101 4426 4429 B-upper_bound
week 102 106 4430 4434 I-upper_bound
prior 107 112 4435 4440 I-upper_bound
to 113 115 4441 4443 O
the 116 119 4444 4447 O
first 120 125 4448 4453 O
date 126 130 4454 4458 O
of 131 133 4459 4461 O
study 134 139 4462 4467 O
treatment 140 149 4468 4477 B-treatment

at 0 2 4478 4480 O
least 3 8 4481 4486 O
18 9 11 4487 4489 B-lower_bound
years 12 17 4490 4495 I-lower_bound
of 18 20 4496 4498 O
age 21 24 4499 4502 B-age

